![]() |
市场调查报告书
商品编码
1934740
深度过滤:市场占有率分析、产业趋势与统计资料、成长预测(2026-2031)Depth Filtration - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031) |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计深度过滤市场将从 2025 年的 30.6 亿美元成长到 2026 年的 33.4 亿美元,到 2031 年将达到 52.2 亿美元,2026 年至 2031 年的复合年增长率为 9.31%。

生物製药厂商必须满足最新的病毒安全法规,因此对深度过滤器的需求强劲,加之经济高效的一次性使用技术,共同推动了这一领域的扩张。滤芯和滤囊的创新使得深度过滤器的更换率居高不下,因为製药、食品、饮料和水处理公司都将深度过滤器视为抵御颗粒物和微生物污染物的第一道重要屏障。设备供应商的整合、向不含 PFAS 的滤材过渡的趋势以及亚太地区产能的快速扩张,都在扩大市场机会的同时加剧竞争。硅藻土原料供应的紧张和日益严格的废弃物处理法规虽然抑制了成长,但也为永续纤维素替代品创造了新的市场机会。
随着生物製剂产能的扩张,对能够实现高细胞密度下大规模批量纯化的深度过滤器的需求持续成长。FUJIFILM在北卡罗来纳州投资12亿美元扩建的16万公升反应器项目,清楚展现了大型不锈钢和一次性生产线如何推动对纯化产能的需求。抗体市场预计到2030年将以每年8%的速度成长,这迫使像AGC Biologics这样的契约製造生产商将其一次性生物反应器的产能翻番,从而直接提高了过滤器的更换频率。高产量目标要求深度过滤器兼具高通量和低产品损失,这赋予了供应商更高的定价权。虽然生物相似药的上市加剧了成本压力,但由于纯度规格很少会受到影响,因此预计这一趋势将长期持续下去。
一次性胶囊和堆迭式圆盘模组最大限度地减少了清洁验证工作,降低了交叉污染风险,并缩短了换型时间。 Cytiva 和 Pall 已投资 3 亿美元,在全球 13 个地点扩大一次性产品产能,这再次表明了他们对该技术未来发展的信心。旭化成 (Asahi Kasei) 的 Planova SU-VFC 装置整合了与 cGMP 设施相容的自动化压力控制系统,减少了操作人员的干预。食品和饮料加工商也纷纷效仿,在不增加水或化学品消耗的情况下满足过敏原管理要求。儘管人们对可回收性仍有担忧,但监管机构对一次性生产线的持续支持正在推动其普及应用。
切向流系统可在单一连续设备中实现浓缩和过滤,从而减少残留体积和操作人员接触点。 Repligen 的自动化盒式设备配备在线连续紫外线监测功能,可提高製程控制和扩充性,并协助企业避免深度过滤瓶颈。膜成本的下降和精确的分子量截留使得切向流过滤在某些高价值治疗药物领域具有经济竞争力。连续生产模式正在加速切向流过滤技术的应用,尤其是在可以避免使用传统间歇式设备的新建工厂。因此,深度过滤供应商必须不断创新,否则将面临市场占有率流失的风险。
到2025年,滤芯过滤器仍将占据深度过滤市场最大份额,收入占比达37.79%,这反映了其在现有不銹钢管线和水务设施中的广泛应用。由于终端用户重视可预测的更换週期和广泛的化学相容性,滤芯深度过滤市场规模持续稳定成长。然而,受一次性原料药(API)生产需求的推动,胶囊式过滤器预计到2031年将以9.66%的复合年增长率成长。一次性原料原料药生产受惠于无需CIP检验的封闭式更换系统。先进的胶囊式过滤器设计整合了预过滤器和排气口,从而减少了在空间有限的无尘室中的面积。 《基因工程与生物技术新闻》报道称,细胞和基因治疗机构对胶囊式过滤器的应用日益广泛,这标誌着一次性产品市场正迎来转捩点。
产品创新进一步模糊了产品类别的界限,混合式迭盘式滤芯模组结合了过滤过滤层,在扩大处理能力的同时,也能保护下游病毒过滤器。为了符合新的欧洲法规,供应商如赛多利斯(Sartorius)计划在2025年推出不含PFAS的高通量型号,同时提供与现有产品相当的流量性能。在葡萄酒、啤酒和血浆产业,过滤片和滤芯仍然至关重要,因为这些产业拥有数十年的营运经验和较低的资本成本,足以抵消转换成本。总体而言,产品发展趋势表明,市场正朝着多功能滤芯和滤囊的方向发展,这些滤芯和滤囊能够在不影响永续性目标的前提下提供可扩展的性能,从而保持深度过滤市场的竞争力和创新性。
硅藻土凭藉其高污泥截留能力和成本优势,预计2025年将持续维持39.78%的市占率。然而,依赖硅藻土介质的深层过滤市场正面临挑战,国际纸业公司关闭位于乔治城的工厂,导緻美国绒毛浆产量减少5%,原料成本波动加剧。同时,随着监管机构和买家优先考虑可堆肥和不含PFAS的介质,纤维素介质预计将以9.93%的复合年增长率成长。麻省理工学院正在开发的新型丝-纤维素复合材料预示着一系列生物基材料的出现,这些材料有望进一步减少对矿物开采的依赖。
活性碳复合复合材料负责去除饮料中的异味、异味和色泽,而珍珠岩仍是高温化学製程的主要介质。供应商正在将吸附剂粉末掺入纤维素垫中,以製造多功能深层吸附层,无需单独的过滤步骤即可捕获微量有机物。随着介质创新兼顾性能和环境指标,纤维素的可再生和广泛的供应基础为其市场份额增长提供了机会,而硅藻土已确立的成本优势和机械强度表明,在预测期内,两者将并存。
到2025年,北美将占全球收入的41.92%,这主要得益于波士顿、旧金山和三角研究园区等成熟的生物製药产业丛集,这些企业持续投资升级过滤器,以符合FDA关于病毒去除的指导方针。美国本土供应商正在加强其区域供应链,例如Purolite在宾州新建的树脂工厂和Perle在新加坡的扩张计划,这些都将继续为美国客户供应产品。美国对基因治疗生产商的大力财政支持,以及对cGMP合规性的推动,正在推动市场对检验的病毒去除性能的高端深度滤芯的需求。
亚太地区将维持最快增速,到2031年复合年增长率将达到10.78%。中国临床试验的激增以及各省的优惠政策正在推动需要一次性澄清生产线的新型下游製程。在印度,更严格的环境法规以及药品和特种化学品出口应对力的提升正在推动工业过滤的需求。区域政府资助的大型水处理大型企划指定采用深度过滤来去除浊度、色度和全氟烷基物质(PFAS),进一步扩大了目标市场。
由于欧洲拥有历史悠久的疫苗和血浆生产基地,其市场份额仍占据较大份额。然而,能源成本上涨和英国脱欧带来的物流挑战增加了即时过滤器供应的复杂性,促使各地建立本地缓衝库存。南美洲和中东及非洲地区尚不成熟,但蕴藏着巨大潜力,公共卫生投资和海水淡化计划正在催生需求中心。然而,货币波动和政治风险正在减缓私部门的参与。在全球范围内,深度过滤市场正受益于人们对水质的普遍关注、生物製药活动的活性化以及监管趋同——这些因素共同认可了检验的深度过滤工艺作为污染控制的基础。
The depth filtration market is expected to grow from USD 3.06 billion in 2025 to USD 3.34 billion in 2026 and is forecast to reach USD 5.22 billion by 2031 at 9.31% CAGR over 2026-2031.

Strong demand from biopharmaceutical manufacturers that must meet updated viral-safety rules, alongside cost-effective single-use technologies, underpins the expansion. Cartridge and capsule innovations keep replacement rates high, while pharma, food, beverage, and water processors view depth filters as an indispensable first barrier against particulate and microbial contaminants. Consolidation among equipment vendors, the push for PFAS-free media, and Asia-Pacific's rapid capacity additions enhance opportunities but also intensify competitive pressure. Raw-material supply constraints for diatomaceous earth and tighter waste-disposal regulations temper growth yet open white-space for sustainable cellulose alternatives.
Capacity expansion in biologics drives sustained uptake of depth filters that must clarify larger batch volumes at higher cell densities. Fujifilm's USD 1.2 billion North Carolina expansion adding 160,000 L of reactors underscores how larger stainless and single-use trains elevate clarification throughput needs. Antibody segment growth at 8% annually through 2030 forces contract manufacturers such as AGC Biologics to double single-use bioreactor capacity, directly multiplying filter-change frequencies. Elevated output targets demand depth filters that combine high flux with low product loss, placing premium pricing power in suppliers' hands. The trend remains long-lived as biosimilar launches intensify cost-of-goods pressure yet rarely compromise on purity specifications.
Disposable capsules and stacked-disc modules minimize cleaning validation, reduce cross-contamination risk, and shorten changeover times. Cytiva and Pall committed USD 300 million to scale single-use capacity across 13 global sites, reaffirming confidence in the technology's future. Asahi Kasei's Planova SU-VFC unit integrates automated pressure control that fits cGMP suites and cuts operator intervention. Food and beverage processors have followed suit to meet allergen-control mandates without raising water and chemical consumption. Continued regulatory endorsement of disposable trains bolsters adoption, even as recyclability concerns linger.
Tangential-flow systems offer concentration and diafiltration in a single continuous unit, reducing hold-up volumes and operator touches. Repligen's automated cassettes with in-line UV monitoring sharpen process control and scalability, allowing users to bypass depth-filter bottlenecks. Falling membrane costs and precise molecular-weight cutoffs tilt the economics in favor of TFF for certain high-value therapeutics. Continuous-manufacturing paradigms accelerate adoption, particularly in green-field plants that can avoid legacy batch equipment. Depth-filter vendors must therefore innovate or risk share attrition.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Cartridge filters retained the largest slice of the depth filtration market in 2025, standing at 37.79% revenue share, reflecting entrenched usage across legacy stainless-steel lines and municipal-water facilities. The depth filtration market size for cartridge solutions continues to grow at a steady pace as end users value their predictable change-out intervals and broad chemical compatibility. Yet, capsule formats post a 9.66% CAGR through 2031, fueled by single-use drug-substance manufacturing that benefits from closed-system changeovers without CIP validation. Advanced capsule designs integrate pre-filters and vent ports, compressing skid footprints inside constrained clean-rooms. Genetic Engineering & Biotechnology News reports widening adoption across cell-gene therapy suites, hinting at an inflection favoring disposability.
Product innovation further blurs category lines, with hybrid stack-disc modules housing both depth and membrane layers to extend capacity while protecting downstream viral filters. Suppliers such as Sartorius unveiled PFAS-free high-throughput variants in 2025, positioning to comply with upcoming European legislation while providing equivalent flow performance. Filter sheets and modules maintain relevance in wine, beer, and plasma applications where decades of operating know-how and low capital needs outweigh changeover labor. Overall, product evolution suggests convergence toward multipurpose cartridges and capsules that deliver scalable performance without compromising sustainability targets, keeping the depth filtration market competitive and innovation-rich.
Diatomaceous earth dominated with 39.78% share in 2025 owing to its high dirt-holding capacity and favorable cost profile. The depth filtration market size tied to diatomite media faces headwinds after International Paper shuttered its Georgetown mill, removing 5% of U.S. fluff pulp output and raising input-cost volatility. Cellulose media, in contrast, is projected to grow at 9.93% CAGR as regulators and buyers prioritize compostable, PFAS-free options. Novel silk-cellulose hybrids under development at MIT signal a pipeline of bio-based materials that could further erode reliance on mined minerals.
Activated-carbon composites serve taste, odor, and color removal roles in beverages, while perlite remains the media of choice in high-temperature chemical processes. Vendors are blending adsorptive powders into cellulose mats to create multi-functional depth layers that capture trace organics without separate filtration passes. As media innovation tracks both performance and environmental metrics, cellulose's renewable nature and broad supply base position it for incremental share gains, but diatomaceous earth's entrenched cost advantage and mechanical strength signal coexistence over the forecast horizon.
The Depth Filtration Market Report is Segmented by Product Type (Cartridge Filters, Capsule Filters, and More), Media Type (Diatomaceous Earth, Activated Carbon, and More), Application (Final Product Processing, Small-Molecule Processing, and More), End User (Pharmaceutical & Biotechnology Cos., and More), and Geography (North America, and More). The Market Forecasts are Provided in Terms of Value (USD).
North America captured 41.92% of global revenue in 2025, underpinned by mature biologics clusters in Boston, San Francisco, and Research Triangle Park that consistently invest in filter upgrades to comply with FDA guidance on viral reduction. Domestic suppliers strengthen regional supply chains, as highlighted by Purolite's new Pennsylvania resin plant and Pall's Singapore expansion that still funnels product back to U.S. customers. The United States benefits from robust funding for gene-therapy producers, whose adherence to cGMP pushes demand for high-end depth cartridges with validated log-reduction performance.
Asia-Pacific remains the fastest-growing region through 2031 at 10.78% CAGR. China's clinical-trial surge and generous provincial incentives spur new downstream suites requiring single-use clarification lines. India's industrial filtration demand grows on tightening environmental norms and the drive to improve export readiness in pharmaceuticals and specialty chemicals. Regional governments fund water-treatment megaprojects that specify depth filters for turbidity, color, and PFAS removal, further expanding the addressable base.
Europe retains a significant slice due to long-established vaccine and plasma manufacturing. Yet high energy costs and Brexit-related logistics add complexity to just-in-time filter deliveries, incentivizing local buffer stocks. South America and Middle East Africa remain nascent but opportunistic; public health investments and desalination projects create pockets of demand although currency volatility and political risk slow private-sector uptake. Globally, the depth filtration market benefits from universal focus on water quality, heightened biologics activity, and regulatory convergence that recognizes validated depth-filtration steps as foundational to contamination control.